Infinity Pharmaceuticals Stock

Infinity Pharmaceuticals Forward P/E

Forward P/E Ratio of Infinity Pharmaceuticals (INFIQ) as of Aug 4, 2026.

Forward P/E

-0.00

YoY

2.01%

Last updated:

Forward P/E Ratio of Infinity Pharmaceuticals is 2026 -0.00 . Forward P/E Ratio of Infinity Pharmaceuticals was 2025 -0.00 . It decreases by 2.01% lower compared to the previous year.
Access this data via the Eulerpool API

Infinity Pharmaceuticals Stock analysis

What does Infinity Pharmaceuticals do? Infinity Pharmaceuticals Inc. is a biopharmaceutical company based in Cambridge, Massachusetts. It was founded in 2001 and focuses on the discovery and development of novel therapies for cancer and other serious diseases. Infinity Pharmaceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Infinity Pharmaceuticals stock

On Eulerpool you can find the complete historical development of Forward P/E Ratio Infinity Pharmaceuticals since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Infinity Pharmaceuticals with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Infinity Pharmaceuticals

All Key Metrics — Infinity Pharmaceuticals